Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis is a research paper published in npj Vaccines (2021). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Health & Human Services | National Institutes of Health
Grant: ZIA-DC000087
National Institutes of Health
Grant: 1ZIADC000087-03
Characterization and Enhancement of Anti-Tumor Immune Responses in Head and Neck Cancer
FWCI
0.51
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals